When performing in vitro permeation testing (IVPT) for topical semisolid dosage forms and transdermal delivery systems, international regulations (US FDA Draft Guidance on Topical Semisolid Products, EMA Guideline on Quality and Equivalence of Topical Products, USP <1724>) generally strongly recommend or mandate "complete media replacement/complete washout" rather than the "aliquot sampling" commonly used in traditional dissolution tests or IVRT.

The following section provides a comprehensive comparison and in-depth analysis of the text from five dimensions: physiological dynamics, analytical detection limits, leakage conditions, mathematical dilution error amplification, and automated instrument design.

I. Analysis of Core Scientific Mechanisms (Scientific Mechanisms & Rationale)

1. The breakthrough flux is extremely low (pg/mL to ng/mL), and local sampling is very likely to fall below the detection limit (LOD/LOQ).

• Physical limitations of penetration : The human stratum corneum is the strongest biophysical barrier in the human body. IVPT uses a limited dose (finite dose, 5–15 mg/cm²), and in tests lasting 24–48 hours, the total amount of API that actually penetrates into the receptor fluid is often only in the nanogram (ng) or even picogram (pg) range.

• Microsampling dilution blind spot : The receptor chamber volume of a conventional vertical diffusion cell is approximately 5 mL to 12 mL. If only 200 µL to 500 µL of local sample is drawn, the absolute amount of drug drawn by the needle is extremely low, which can easily fall below the limit of quantitation (LOQ) of the LC-MS/MS assay line. This results in a large number of inquantifiable "below-the-limit of quantitation (BQL)" invalid data points during the lag phase in the early stage of the experiment.

• Advantages of full-volume sampling : By extracting the entire 5 mL or 7 mL of medium from the receptor chamber, analysts can directly measure the total mass that has penetrated over the entire time period. Solid-phase extraction (SPE) or nitrogen drying and concentration can also be easily performed, which greatly improves the signal-to-noise ratio (S/N ratio) and quantitative accuracy of micro-mass spectrometry analysis.

2. Realistically reproduces dynamic transdermal flux (J), avoiding interference from concentration accumulation.

• The essence of pharmacokinetics : The key core indicators for IVPT assessment are the flux profile (J) and peak flux (Jmax), which represent "the instantaneous rate at which the drug penetrates the skin within a specific time interval".

• Physical barriers to microsampling : If the receptor fluid is not completely emptied, the drug that has penetrated in the previous time period will continue to remain in the receptor chamber. According to Fick's first law of diffusion (J = -D · dC/dx), the drug concentration accumulated in the receptor chamber will directly reduce the chemical concentration gradient (ΔC) on both sides of the skin, thereby artificially inhibiting the drug penetration rate in subsequent time periods, causing the measured Jmax to be underestimated and the lag period to be falsely prolonged.

• Physiological simulation of full-volume replacement : The receptor fluid is completely drained and replaced with a completely new medium, which is equivalent to instantly resetting the receptor concentration to zero (Zero-sink Reset), perfectly simulating the dynamic circulation physiological state of the human dermal capillary network where "blood flows continuously and carries away penetrating drugs quickly".

3. Prevent the amplification of "dilution accumulation error" caused by multiple partial sampling.

• Micro-sampling recursive compensation for defects : If only Vsample is taken each time, the residual volume of the receptor chamber is (Vtotal - Vsample). When calculating the cumulative penetration at the nth time point, the cumbersome recursive compensation formula must be used: Mn = Cn · Vtotal + ∑(Ci · Vsample).

• Geometric series error amplification : In IVPT tests lasting 24 to 48 hours with as many as 8 to 12 sampling points, any small evaporation, sampling volume tolerance, or instrument fluctuations in the early stages will cause the error to accumulate and be geometrically amplified at subsequent time points. This will ultimately lead to a surge in the coefficients of variation (%RSD) of the pharmacokinetic parameters AUC0-t and Jmax, and may even cause the bioequivalence (BE) comparison to fail.

• Absolute independence of full sampling : During full sampling, what is collected at each time point is the absolute mass of the penetration of that interval (Mass = Concentration × Total Volume). The data at each time point are independent of each other and do not interfere with each other, resulting in the smallest statistical variability and the purest and most reliable data.

4. Strictly maintain the "sink condition" for poorly soluble drugs.

• Limited receptor fluid volume : Most topical active ingredients (such as corticosteroids, antifungal drugs, immunosuppressants such as Tacrolimus) are highly lipophilic and extremely poorly soluble in water, belonging to BCS class II/IV drugs.

• Saturation precipitation and pseudo-plateau : Despite the addition of surfactants or bovine serum albumin (BSA) to the receptor fluid, the volume of the receptor chamber in the diffusion cell is only 5–12 mL. If not completely replaced, the receptor fluid can easily reach 10%–30% of the drug saturation solubility (exceeding the upper limit of the leakage condition) during the middle of the peak penetration rate, resulting in impaired drug penetration and an unnatural "pseudo-plateau" in the flux curve.

• Full replacement guarantee : Each time the fluid is drained and replaced, the recipient fluid is always kept fresh and at an extremely low concentration, ensuring that the entire 24-48 hour test meets the strict leakage conditions specifications 100% of the time.

5. Inhibits microbial growth and receptor fluid matrix deterioration.

• Interference from endogenous skin extracts : When human skin is kept at a constant temperature of 32°C for 24 to 48 hours, trace amounts of proteins, hydrolytic enzymes, lipids, and cellular debris inherent in the skin will inevitably be released into the receptor fluid.

• Full flushing reduces matrix effect : In long-term tests, full drainage of the receptor fluid and replacement with fresh replenishment fluid can effectively wash away and reduce the excessive accumulation of endogenous substances in the receptor fluid, significantly reducing the severe "matrix effect" and ion suppression during subsequent high-sensitivity LC-MS/MS mass spectrometry analysis.

II. Comprehensive Comparison of Key Experimental Operations and Methodologies

• Recommended Sampling Mode

• IVPT (In vitro skin penetration test) : Complete media replacement involves emptying the sample and replacing it with fresh isothermal recipient fluid.

• IVRT (In vitro release assay) : A small local sample (e.g., 200–500 µL) is taken and a small amount of fresh medium is added (Aliquot Sampling).

• Receptor end concentration level

• IVPT : Extremely low concentration levels, mostly in the pg/mL to ng/mL ultra-micro range.

• IVRT : High concentration levels, mostly in the range of µg/mL to mg/mL.

• The cumulative concentration of receptor residues affects

• IVPT : The cumulative concentration of residual substances can significantly reduce the concentration gradient on both sides of the stratum corneum, greatly suppressing subsequent flux.

• IVRT : The receptor medium often contains a high proportion of solubilizers, and trace accumulation does not affect the thermodynamic slope of drug diffusion from the matrix.

• In vivo physiological mechanism simulation localization

• IVPT : It must highly reproduce the microcirculation clearance mechanism by which the dermal capillary network "immediately carries away" penetrating drugs.

• IVRT : Purely in vitro physical matrix thermodynamic release assessment, without considering human microcirculation and metabolic clearance.

• Data calculation and pharmacokinetics model

• IVPT : Non-cumulative mass interval calculation, plots instantaneous flux profile (J) and obtains Jmax and AUC.

• IVRT : Cumulative release calculation, based on the Higuchi model to evaluate the linear regression slope (Release Rate) of the cumulative release percentage against the square root of time (√t).

• Diluting accumulation calculation errors amplify risks.

• IVPT : The quality of each point in the full sample is calculated independently, eliminating the geometric dilution error caused by the continuous accumulation of multiple time points.

• IVRT : It uses a recursive formula to correct for micro-sampling losses. Due to the high overall concentration, it has a high statistical tolerance for small volumetric errors.

• Terminal analysis instruments and sample pretreatment requirements

• IVPT : Highly reliant on ultra-sensitive LC-MS/MS mass spectrometers; full-volume sampling facilitates SPE solid-phase extraction or nitrogen blowing concentration.

• IVRT : A standard HPLC-UV ultraviolet light detector can meet the requirements for accurate quantification, and the sample volume is more than sufficient for micro-sampling.

III. Challenges of Full Sampling Operations and Logan Automation Solutions

While full sampling is absolutely necessary from both a regulatory and scientific perspective, traditional manual operation is prone to three major bottlenecks:

• Air bubbles on the underside of the skin : When the skin is completely emptied and refilled, tiny air bubbles are very likely to form on the underside of the skin. The area of skin covered by the air bubbles will lose its diffusion effect, directly rendering the experimental data invalid.

• Severe fluctuations in receptor chamber temperature : Manually injecting insufficiently preheated cold refill fluid can cause the skin surface temperature to drop sharply from 32°C, severely disrupting the penetration dynamics.

• Long-term human fatigue : IVPT often spans 24 to 48 hours, and nighttime sampling points are prone to human delays, incomplete drying, or correction of scale errors.

Qinwei Technology's technical solution: Logan Transdermal Dilation Fully Automated System (USA)

• Vertical dry heat diffusion system: Logan System 918 / DHC-6TD with DSC-800 sampling workstation

• Patented Bubble-Free Lateral Sampling Arm : During the full emptying and full replenishment process, the patented fluid dynamics geometric arc structure can automatically guide the discharge of microbubbles, ensuring 100% tight contact between the skin surface and the receptor medium.

• High-precision bidirectional push-pull syringe pump (SYP series) : Precisely executes the process of "draining the receptor chamber completely → injecting the sample vial → simultaneously injecting fresh medium of equal volume and temperature (preheated at 37°C / skin temperature 32°C)," completing the process smoothly and automatically within tens of seconds, eliminating temperature shocks and human error.

• Next-generation circulation pool system: Logan FTC-800 Flow-Through Diffusion System (compliant with USP <1724>)

• In-situ Continuous Washout : For highly sensitive, lipophilic trace drugs, the FTC-800 continuously removes receptor fluid with a pulseless precision microfluidic flow rate of 0.1–4.0 mL/min, ensuring that the bottom of the receptor cell always maintains 100% fresh medium, naturally achieving "continuous full-volume elution" without the need for intermittent exchange and oscillation. The eluent can be directly connected to subsequent LC-MS/MS injection analysis.

IV. Conclusion

The "full sampling and full recovery" approach adopted by IVPT is not merely a matter of experimental preference, but a regulatory necessity to overcome the limitations of stratum corneum microfluidic throughput, maintain strict leakage conditions, reproduce the physiological dynamics of dermal capillary clearance, and eliminate mathematical geometric accumulation errors. By introducing advanced automated transdermal diffusion instruments that comply with FDA 21 CFR Part 11 and USP <1724> regulations, pharmaceutical R&D teams can be provided with highly accurate, reproducible, and fully compliant transdermal absorption and penetration data, free from bubble interference and temperature shock.

Professional consultation and online sample testing planning

Welcome to visit the DS website by clicking the link below, or fill out the online consultation form. Our professional technical consultants will plan a customized regulatory compliance and equipment selection solution for your laboratory.

• Official website : www.dissolution.com.tw

• Product Section : USP1724 Transdermal Absorption

• Technical consultation hotline : 04-2241-1607